EEF2 and breast cancer: Similarly, for patients with basal-like breast cancer (PAM50 subtype), high eEF2 K expression correlated with reduced OS (HR = 1.84, log-rank p = 0.02), further emphasizing the negative impact of eEF2 K on patient prognosis.